Comparison of Biosimilar Filgrastim with Innovator Fligrastim for Peripheral Blood Stem Cells Mobilization, Collection of CD34+ Stem Cells, and Engraftment in Patients Undergoing Autologous and Allogeneic Stem Cell Transplantation: A Single-Center Experience

BACKGROUND: In the Middle East, there is lack of data on peripheral blood CD34+stem cells mobilization by using biosimilar filgrastim. We have been using both Neupogen and a biosimilar G-CSF) Zarzio(®) (as a mobilizing agent since February 2014 for both allogenic and autologous stem cell transplanta...

Descripción completa

Detalles Bibliográficos
Autores principales: Islami, Maha M., Khan, Mansoor Ahmed, Aseeri, Mohammed A., Alshamrani, Majed A., Alnatsheh, Abdelmajid, Alamoudi, Sameer, Alzahrani, Ahmed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2023
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990321/
https://www.ncbi.nlm.nih.gov/pubmed/36864713
http://dx.doi.org/10.12659/AOT.938585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990321/
https://www.ncbi.nlm.nih.gov/pubmed/36864713
http://dx.doi.org/10.12659/AOT.938585

Ejemplares similares